Ryvu Company
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Poland
Founded Date:
2007
Employees Number:
101-250
Funding Status:
IPO
Estimated Revenue:
$50M to $100M
Register and Claim Ownership